Echocardiography of Right Ventricle in Patients with Schistosomiasis-induced Pulmonary Hypertension

Echocardiographic in pulmonary hypertension: evaluation of the right heart chambers and pulmonary artery

“…A similar study composed of a sample of 50 individuals with PH and 50 individuals without PH who intended to evaluate the presence of right ventricular dysfunction and alterations in the right cardiac chambers concluded that there is consistently dilation in the cardiac chambers, except direitas, concluiu que se verifica consistentemente dilatação nas câmaras cardíacas, à exceção do VE, no grupo com HP (Lopes et al, 2020). O que está documentado na bibliografia é então um aumento crescente das cavidades cardíacas com a pós-carga devido a um aumento das resistências vasculares pulmonares na presença de HP (Conde RE et al, 2021;Castillo et al, 2016).…”

“…O valor da PSAP demonstrou ser um importante parâmetro a ter em conta, seja no diagnóstico, ou no acompanhamento terapêutico nestes pacientes, sendo este for the left ventricle, in the group with PH (Lopes et al, 2020). What is documented in the bibliography is then an increasing increase in cardiac cavities with postload due to an increase in pulmonary vascular resistance in the presence of PH (Conde RE et al, 2021;Castillo et al, 2016). The second point of the results revealed that the greater the PSAP, the greater the size of the right cardiac chambers and PA, and the finding in the LVD without statistical significance (p>0.05).…”

The Use of Echocardiography in Schistosomiasis

“…The long-term evolution of patients with schistosomiasis showed elevated mortality, with larger dimensions of the right ventricle, lower fractional area change, lower tricuspid annular systolic velocity, and lower right ventricular global longitudinal strain. 4 A systematic review has shown that patients with schistosomiasis-associated PAH have more favorable hemodynamic profile and survival rate than those with idiopathic PAH. 5 Although there are reports of cardiac complications of this infection, they have not yet been validated by robust population data.…”